Compare ENVB & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENVB | VNRX |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.3M |
| IPO Year | 2000 | 2012 |
| Metric | ENVB | VNRX |
|---|---|---|
| Price | $1.41 | $0.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $12.03 |
| AVG Volume (30 Days) | 27.5K | ★ 1.8M |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,914,675.00 | $1,727,384.00 |
| Revenue This Year | N/A | $68.91 |
| Revenue Next Year | N/A | $279.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $1.17 | $0.13 |
| 52 Week High | $795.00 | $3.26 |
| Indicator | ENVB | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 39.23 |
| Support Level | $1.35 | $0.15 |
| Resistance Level | $1.55 | $0.18 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 22.73 | 6.14 |
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.